Home NDC 58198-7210 NDC 58198-7210 - Increxxa 25 This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 58198-7210
Package NDCs from labels 58198-7210-2, 58198-7210-3
Manufacturer Elanco US Inc.
Effective date 2025-10-28
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 58198-7210-2 Increxxa 25 100 mL in 1 BOTTLE, GLASS INJECTION 100 3 58198-7210-2 Increxxa 25 1 in 1 CARTON INJECTION 1 3 58198-7210-3 Increxxa 25 1 in 1 CARTON INJECTION 1 3 58198-7210-3 Increxxa 25 250 mL in 1 BOTTLE, GLASS INJECTION 250 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 58198-7210 INCREXXA 25 (TULATHROMYCIN) INJECTION [ELANCO US INC.] 2 4 package rows 20220414_e20cb05c-4718-4e26-a076-a77347898b3b.zip
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.